Page last updated: 2024-08-25

rosiglitazone and N-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoylethanolamine

rosiglitazone has been researched along with N-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoylethanolamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Andò, S; Augimeri, G; Barone, I; Bonofiglio, D; Catalano, S; Gelsomino, L; Gionfriddo, G; Giordano, C; Giordano, F; Morelli, C; Plastina, P; Sisci, D; van Norren, K; Witkamp, R	1

Other Studies

1 other study(ies) available for rosiglitazone and N-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoylethanolamine

Article	Year
Modulating Tumor-Associated Macrophage Polarization by Synthetic and Natural PPARγ Ligands as a Potential Target in Breast Cancer. Cells, 2020, 01-10, Volume: 9, Issue:1 Topics: Breast Neoplasms; Cell Differentiation; Cell Line; Cell Polarity; Culture Media, Conditioned; Cytokines; Docosahexaenoic Acids; Ethanolamines; Female; Humans; Ligands; Molecular Targeted Therapy; Monocytes; PPAR gamma; Rosiglitazone; Tumor-Associated Macrophages	2020

Article

Year

Modulating Tumor-Associated Macrophage Polarization by Synthetic and Natural PPARγ Ligands as a Potential Target in Breast Cancer.

Cells, 2020, 01-10, Volume: 9, Issue:1

Topics: Breast Neoplasms; Cell Differentiation; Cell Line; Cell Polarity; Culture Media, Conditioned; Cytokines; Docosahexaenoic Acids; Ethanolamines; Female; Humans; Ligands; Molecular Targeted Therapy; Monocytes; PPAR gamma; Rosiglitazone; Tumor-Associated Macrophages

2020